 |
市場調查報告書
商品編碼
2008143
布氏桿菌症疫苗市場：按類型、應用和地區分類Brucellosis Vaccines Market, By Type, By Application, By Geography |
||||||
2026年布氏桿菌症疫苗市場規模估計為12億美元，預計2033年將達24億美元。預計2026年至2033年，該市場將以7.3%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 12億美元 |
| 業績數據週期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026-2033年預測期間的複合年成長率： | 7.30% | 2033年市場規模預測： | 24億美元 |
布氏桿菌症是一種由細菌引起的感染疾病。最常感染的動物包括綿羊、牛、山羊、豬和狗。人類也可能因接觸受感染的動物或被細菌污染的動物製品而感染此病。
此外，動物布氏桿菌症可透過 RB51、S19、B19 等疫苗以及其他疫苗（45/20、SR82 等）進行治療。
此外，布氏桿菌症疫苗接種計劃的日益普及預計將在預測期內推動市場成長。
2021 年 8 月，印度曼尼普爾邦圖瓦爾啟動了一項布魯氏菌病疫苗接種計劃，目標是 4 至 8 個月大的雌性牛，目的是控制和根除布氏桿菌症。
市場動態
預計在預測期內，布氏桿菌症日益普遍將推動全球布氏桿菌症疫苗市場的成長。例如，根據美國國家生物技術資訊中心（NCBI）發表的報導稱，布氏桿菌症是世界上傳播最通用的感染疾病，屬於動物傳染給人類的疾病。 NCBI經營一系列與生物技術和生物醫學相關的資料庫。據同一資訊來源稱，全球每年報告的人類布氏桿菌症病例達50萬例。然而，據估計，全球整體每年實際病例數在500萬至1250萬例之間。
據同一資訊來源稱，布氏桿菌症是世界上最常見的實驗室感染。
本次調查的主要特點
- 本報告以 2021 年為基準年，對全球布氏桿菌症疫苗市場、市場規模和預測期（2022-2030 年）的複合年成長率進行了詳細分析。
- 本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本報告根據以下參數介紹了全球布氏桿菌症疫苗市場的主要企業概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過對全球布氏桿菌症疫苗市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 研究目標
- 前提
- 簡稱
第2章 市場範圍
- 報告摘要
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 促進因素
- 抑制因子
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 產品發布
- 監管指南
- 收購、合作與夥伴關係
- 流行病學
- PEST分析
第4章 全球布氏桿菌症疫苗市場：按類型分類，2026-2033年
- RB51疫苗
- S19疫苗
- B19疫苗
- 其他疫苗（45/20疫苗、SR82疫苗等）
第5章 全球布氏桿菌症疫苗市場：依應用領域分類，2026-2033年
- 牛
- 羊
- 山羊
- 其他（豬、馬等）
第6章 全球布氏桿菌症疫苗市場：依地區分類，2026-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 南非
- 中非
- 北非
第7章 競爭情勢
- 衝突簡介
- Merck &Co., Inc.
- CZ Vaccines
- Colorado Serum Company
- Indian Immunologicals Ltd.
- Hester Biosciences Limited
- Veterinary Technologies Corporation
- Jordan Bio-industries Center
- Laboratorios Tornel
- Fivet Animal Health
- VETAL Animal Health Products Inc.
第8章
- 參考
- 調查方法
Brucellosis Vaccines Market is estimated to be valued at USD 1.2 Bn in 2026 and is expected to reach USD 2.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.30% | 2033 Value Projection: | USD 2.4 Bn |
Brucellosis is an infectious disease caused by bacteria. Animals that are most commonly infected include sheep, cattle, goats, pigs, and dogs, among others. These disease can also occur in humans when they are in contact with infected animals or animal products contaminated with bacteria.
Moreover, RB51 Vaccine, S19 Vaccine, B19 Vaccine and Others (45/20 vaccine, SR82 vaccine, etc.) are the type of vaccine used for the brucellosis in animals.
Furthermore, increasing launches of brucellosis vaccination programmes is expected to drive the market growth over the forecast period.
In August 2021, brucella vaccination program was launched at Thoubal, Manipur, India for the control and eradication of brucellosis in female calves of 4-8 months age group.
Market Dynamics
Increasing prevalence of brucellosis is expected to drive the global brucellosis vaccines market growth over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, brucellosis is the world's most widespread zoonotic disease, a type of disease that passes from an animal to a human. The source stated that there are a reported 500,000 cases of human brucellosis each year, globally. However, true incidence is estimated to be 5,000,000 to 12,500,000 cases each year, globally.
According to the same source, brucellosis is recognized as the world's most common laboratory-acquired infection.
Key features of the study
- This report provides an in-depth analysis of the global brucellosis vaccines market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global brucellosis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., CZ Vaccines, Colorado Serum Company, Indian Immunologicals Ltd., Hester Biosciences Limited, Veterinary Technologies Corporation, Jordan Bio-industries Center, Laboratorios Tornel, Fivet Animal Health and VETAL Animal Health Products Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global brucellosis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brucellosis vaccines market
Market Segmentation
- By Type
- RB51 Vaccine
- S19 Vaccine
- B19 Vaccine
- Others (45/20 vaccine, SR82 vaccine, etc.)
- By Application
- Cattle
- Sheep
- Goat
- Others (swine, horses, etc.)
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- CZ Vaccines
- Colorado Serum Company
- Indian Immunologicals Ltd.
- Hester Biosciences Limited
- Veterinary Technologies Corporation
- Jordan Bio-industries Center
- Laboratorios Tornel
- Fivet Animal Health
- VETAL Animal Health Products Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Market Trends
- Key Developments
- Product Launch
- Regulatory Guidelines
- Acquisitions, Collaborations, & Partnerships
- Epidemiology
- PEST Analysis
4. Global Brucellosis Vaccines Market, By Type, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- RB51 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- S19 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- B19 Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (45/20 vaccine, SR82 vaccine, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Brucellosis Vaccines Market, By Application, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sheep
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Goat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (swine, horses, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Brucellosis Vaccines Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- North America
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Region/Country, 2021-2033, (USD Bn)
- South Africa
- Central Africa
- North Africa
7. Competitive Landscape
- Competitive Snapshot
- Merck & Co., Inc.
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CZ Vaccines
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Colorado Serum Company
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Indian Immunologicals Ltd.
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hester Biosciences Limited
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Veterinary Technologies Corporation
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Jordan Bio-industries Center
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Laboratorios Tornel
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fivet Animal Health
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- VETAL Animal Health Products Inc.
- Company Overview
- Application Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
8. Section
- References
- Research Methodology
- About us and Sales Contact
